Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitations

被引：24

作者：

Bourhis, J

Etessami, A

Wilbault, P

Lusinchi, A

Calais, G

Lapeyre, M

Pignon, JP

机构：

[1] Inst Gustave Roussy, Dept Radiat Oncol, F-94805 Villejuif, France

[2] Inst Gustave Roussy, Dept Stat, F-94805 Villejuif, France

[3] CHU Tours, Clin Oncol & Radiotherapie, Tours, France

[4] Ctr Alexis Vautrin, Nancy, France

来源：

CURRENT OPINION IN ONCOLOGY | 2004年 / 16卷 / 03期

关键词：

head and neck squamous cell carcinoma; hyperfractionation; accelerated radiotherapy; acute and late effects;

D O I：

10.1097/00001622-200405000-00004

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Purpose of review This article provides an overview of randomized studies of altered fractionated radiotherapy (RT) in Head and Neck squamous cell carcinoma. Recent findings Both hyperfractionated RT and accelerated RT may improve tumor control probability as compared to conventional RT, along with increased but manageable toxicity and a modest improvement in survival. Summary Altered RT is a tool that can improve the results obtained with conventional RT in Head and squamous cell carcinoma.

引用

页码：215 / 219

页数：5

共 27 条

[1]

Ang KK, 2002, CANCER RES, V62, P7350

[2] Altered fractionation and combined radio-chemotherapy approaches: pioneering new opportunities in head and neck oncology [J].

Bernier, J ;

Bentzen, SM .

EUROPEAN JOURNAL OF CANCER, 2003, 39 (05) :560-571

[3] Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 Gy in 7 weeks [J].

Bourhis, J ;

Dendale, R ;

Hill, C ;

Bosq, J ;

Janot, F ;

Attal, P ;

Fortin, A ;

Marandas, P ;

Schwaab, G ;

Wibault, P ;

Malaise, EP ;

Bobin, S ;

Luboinski, B ;

Eschwege, F ;

Wilson, G .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (03) :471-476

[4]

Bourhis J., 2002, International Journal of Radiation Oncology Biology Physics, V54, P71, DOI 10.1016/S0360-3016(02)03180-2

[5]

BOURHIS J, 2000, P AN M AM SOC CLIN, V19, P412

[6] Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer [J].

Brizel, DM ;

Albers, ME ;

Fisher, SR ;

Scher, RL ;

Richtsmeier, WJ ;

Hars, V ;

George, SL ;

Huang, AT ;

Prosnitz, LR .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (25) :1798-1804

[7]

Budach V. G., 2003, International Journal of Radiation Oncology Biology Physics, V57, pS153, DOI 10.1016/S0360-3016(03)00925-8

[8]

CUMMINGS B, 2000, RADIOTHER ONCOL S1, pS8

[9]

DATTA N R, 1989, International Journal of Radiation Oncology, Biology, Physics, V17, P132

[10] Late toxicity results of the Gortec 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: Comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems [J].

Denis, F ;

Garaud, P ;

Bardet, E ;

Alfonsi, M ;

Sire, C ;

Germain, T ;

Bergerot, P ;

Rhein, B ;

Tortochaux, J ;

Oudinot, P ;

Calais, G .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (01) :93-98

← 1 2 3 →